CSPC Leading Top 100 in R&D Strength Again

June 25, 2023

On June 16-17, 2023, "2023 Conference on High Quality Development of Healthcare Industry & the Eighth Summit for China Pharmaceutical R&D Innovation" was held in Chongqing. During the meeting, the series lists of "2023 China Drug R&D Strength Rankings" selected by the Organizing Committee of the Eighth Summit for China Pharmaceutical R&D Innovation and the Expert Committee of 2023 China Drug R&D Strength Ranking were released.

CSPC Pharmaceutical Group ("CSPC") ranked 6th in the overall list and 4th in the list of chemical drug-makers this year.

The series lists were determined after comprehensive statistical analysis of many R&D-related data, such as drug acceptance and approvals of enterprises, R&D investment of pharmaceutical companies, clinical trials of drugs, and patents and historical drug R&D rankings of enterprises in 2022, by Yaozh.com, the expert committee of Drug R&D Strength Ranking and the organizing committee of 2023 Summit for China Pharmaceutical R&D Innovation.

Previous: CSPC Won the First Hebei Charity Award!

Next: Presentation of Research Achievements of CSPC at the Annual Meeting of AACR